Gabapentin Monotherapy for Refractory Seizures

J Gordon Millichap

doi:10.15844/pedneurbriefs-11-10-12

$Gabapentin Monotherapy for Refractory Seizures Cover$

Gabapentin Monotherapy for Refractory Seizures

Pediatric Neurology Briefs

Volume 11 (1997): Issue 10

By: J Gordon Millichap

Open Access

|Oct 1997

Abstract

The results of an 8-day, controlled, multicenter study of gabapentin monotherapy in 82 hospitalized patients with refractory complex partial or secondarily generalized seizures are reported by members of the US Gabapentin Study Group.

References

Bergey GK Morris HH Rosenfeld W Blume WT Penovich PE Morrell MJ Gabapentin monotherapy: I. An 8-day, double-blind, dose-controlled, multicenter study in hospitalized patients with refractory complex partial or secondarily generalized seizures. The US Gabapentin Study Group 88/89 Neurology 1997 Sep 49 3 739 45 10.1212/WNL.49.3.739 9305334
Open DOI Search in Google Scholar Back to article
Beydoun A Fischer J Labar DR Harden C Cantrell D Uthman BM Gabapentin monotherapy: II. A 26-week, double-blind, dose-controlled, multicenter study of conversion from polytherapy in outpatients with refractory complex partial or secondarily generalized seizures. The US Gabapentin Study Group 82/83 Neurology 1997 Sep 49 3 746 52 10.1212/WNL.49.3.746 9305335
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-11-10-12 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 79 - 79

Published on: Oct 1, 1997

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Gabapentin Monotherapy,

Antiepileptic Medications,

Prolonged/Intensified Seizures

© 1997 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 11 (1997): Issue 10